Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited

Conducts pharmaceutical research and development for therapeutic purposes.
2006 | Hyderabad, Telangana (India) | Under Dissolution

Last Updated:

April 24, 2024
HomeCompanyEpr Gene Technologies Private Limited

Who are the key members and board of directors at Epr Gene Technologies?

Board Members(2)

NameDesignationAppointment DateStatus
Markandeya Gorantla In Director 10-Jul-2015Current
Onteddu Nirmala In Director 27-Nov-2006Current

Financial Performance of Epr Gene Technologies.

Epr Gene Technologies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 52.43% decrease. The company also saw a substantial fall in profitability, with a 837.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.42%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-52.43%
Revenue from Operations
Total Assets
-62.31%
Profit or Loss
-837.99%
Net Worth
-62.42%
EBITDA
-435.17%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹2.70 Cr

LenderAmountStatus

Karvy Financial Services Limited

Creation Date: 02 Oct 2011
₹2.70 CrSatisfied

How Many Employees Work at Epr Gene Technologies?

Unlock and access historical data on people associated with Epr Gene Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Epr Gene Technologies

Recent activity within the organization

  • Annual General Meeting

    Epr Gene Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Epr Gene Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Markandeya Gorantla was appointed as a Director was appointed as a Director on 10 Jul 2015 & has been associated with this company since 9 years 6 months .

    10 Jul 2015

  • Charges

    A charge registered on 02 Oct 2011 via Charge ID 10319591 with Karvy Financial Services Limited was fully satisfied on 20 Aug 2014.

    20 Aug 2014

  • Charges

    A charge with Karvy Financial Services Limited amounted to Rs. 2.70 Cr with Charge ID 10319591 was registered on 02 Oct 2011.

    02 Oct 2011

  • Director Appointment

    Onteddu Devi Nirmala was appointed as a Director was appointed as a Director on 27 Nov 2006 & has been associated with this company since 18 years 1 month .

    27 Nov 2006

Frequently asked questions

  • Epr Gene Technologies Private Limited was incorporated on 27 Nov 2006.

  • The authorized share capital of Epr Gene Technologies Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.50 Cr.

  • Currently 2 directors are associated with Epr Gene Technologies Private Limited.

    • Markandeya Gorantla
    • Onteddu Devi Nirmala
  • As per Ministry of Corporate Affairs (Mca), the registered address of Epr Gene Technologies Private Limited is Plot-557 Road No.31, Jubilee Hills, Hyderabad, Telangana, India, 500033.

  • The corporate identification number (CIN) of Epr Gene Technologies Private Limited is U72200TG2006PTC051816 and the company number is 051816 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Epr Gene Technologies Private Limited has fallen by -52.43%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Epr Gene Technologies Private Limited has experienced an downturn of -62.42%.

  • The most recent Balance Sheet for Epr Gene Technologies Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Pharma Contract R&D